Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Portal Pharmaceutical, Inc.
WARNING LETTER
•Portal Pharmaceutical, Inc.

Portal Pharmaceutical, Inc. – FDA Warning Letter

Record Details

On November 9, 2009, the FDA issued a Warning Letter to Portal Pharmaceutical, Inc. following an inspection in June 2009 of (b)(4), a contract manufacturer for Portal Pharmaceutical. The letter states that Portal Pharmaceutical, Inc. distributed drug products, including (b)(4) and (b)(4), manufactured by (b)(4), which are considered "new drugs" under section 201(p) of the Act [21 U.S.C. § 321(p)].

These products lack FDA-approved applications, violating sections 301(d) and 505(a) of the Act [21 U.S.C. §§ 331(a), (d) and 355(a)]. Additionally, as prescription drugs intended for conditions not amenable to self-diagnosis, their labeling fails to bear adequate directions for use, causing them to be misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)]. The products are also deemed adulterated under 21 U.S.C. 351(a)(2)(B).

Portal Pharmaceutical, Inc. is responsible for investigating and correcting these violations and preventing recurrence. Failure to promptly correct violations may result in legal action, including seizure and injunction. The firm must

Company
Portal Pharmaceutical, Inc.
Product type
Drugs
Office
San Juan District Office
Person
  • Maridalia Torres-Irizarry ( District Director )
View Company Profile

ID · cacd6f85-6bd9-43b6-b44f-0a955a0c57ee

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 355(b)21 U.S.C. 355(j)21 U.S.C. 352(f)(1)21 CFR 201.521 CFR 201.11521 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Portal Pharmaceutical, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.